Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Update

Alpha Tau Medical Ltd. (NASDAQ:DRTS) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 72,600 shares, an increase of 7.1% from the December 31st total of 67,800 shares. Based on an average daily trading volume, of 45,600 shares, the short-interest ratio is currently 1.6 days. Currently, 0.1% of the shares of the company are sold short.

Alpha Tau Medical Stock Performance

Alpha Tau Medical stock traded down $0.14 during trading on Tuesday, reaching $3.40. The company had a trading volume of 53,348 shares, compared to its average volume of 151,807. Alpha Tau Medical has a 1-year low of $1.75 and a 1-year high of $4.39. The firm’s 50-day simple moving average is $3.35 and its 200 day simple moving average is $2.63. The firm has a market capitalization of $237.38 million, a PE ratio of -7.90 and a beta of 0.83.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reissued a “buy” rating and set a $9.00 price target on shares of Alpha Tau Medical in a research report on Friday, November 22nd.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.